NewGenIvf Group Limited
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $2.7M
- Price
- $0.0987
- % Change (Daily % change from the live per-ticker quote feed.)
- -10.27%
- Volume
- 12.5M
About
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.
Quick stats
Shares outstanding27.3M
Computed float1.7M
Float / shares6.1%
Cash runway (months)1.9
Key info
SectorHealthcare
IndustryMedical - Care Facilities
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001981662
Websitehttps://www.nivf.global
AI Summary
AI-generated1/17
standardbearishoffering
NewGen Announces Closing of $1.25 Million Public Offering
NewGenIvf Group closed a best-efforts public offering raising approximately $1.25 million gross, via 17,857,143 Class A Ordinary Shares and pre-funded warrants priced at $0.07 per share.
Nearly the entire offering (17,732,143 shares) was issued as pre-funded warrants with a nominal $0.00001 exercise price, immediately exercisable, maximizing potential dilution.
Proceeds are earmarked for investment in K25.ai, restructuring of debt securities, working capital including Nodexus machine deployment, and general corporate purposes; Aegis Capital Corp. acted as exclusive placement agent and the deal closed September 30, 2026.
Red flags
- offering priced at $0.07 per share -- penny-stock level dilution into a micro-cap
- vast majority of offering issued as immediately exercisable pre-funded warrants, maximizing dilution
- use of proceeds includes restructuring of debt securities, signaling balance-sheet stress